Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (291-300 of 681) with videos related to

Pageof 69
Sort By:
Cancer|May 21, 2011
Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancerLaura J Havrilesky, Robin Pokrzywinski, Dennis Revicki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2003
No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North CarolinaJohnathan M Lancaster, Robert M Wenham, Susan Halabi, et al.
Critical Reviews in Oncology/Hematology|August 30, 2021
Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysisZiad Bakouny, Emre Yekedüz, David A Braun, et al.
International Journal of Cancer|May 8, 2000
ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancersH Peng, F Xu, R Pershad, et al.
Gynecologic Oncology Reports|July 26, 2016
Performance of sentinel lymph node biopsy in high-risk endometrial cancerJessie Ehrisman, Angeles Alvarez Secord, Andrew Berchuck, et al.
Gynecologic Oncology|February 15, 2003
Specific keynote: genome copy number abnormalities in ovarian cancerJoe W Gray, Seiji Suzuki, Wen-Lin Kuo, et al.
Leukemia Research|February 14, 2014
A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemiaDaniel J Deangelo, Donna Neuberg, Philip C Amrein, et al.
Gynecologic Oncology|June 3, 2006
Progestin and estrogen potency of combination oral contraceptives and endometrial cancer riskG L Maxwell, J M Schildkraut, B Calingaert, et al.
Gynecologic Oncology|July 1, 2008
Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrenceLaura J Havrilesky, Clark M Whitehead, Jennifer M Rubatt, et al.
Psychological Trauma : Theory, Research, Practice and Policy|September 22, 2015
Subthreshold posttraumatic stress disorder: A meta-analytic review of DSM-IV prevalence and a proposed DSM-5 approach to measurementMira Brancu, Monica Mann-Wrobel, Jean C Beckham, et al.
Pageof 69

Showing results (291-300 of 681) with videos related to

Sort By:
Pageof 69
Cancer|May 21, 2011
Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancerLaura J Havrilesky, Robin Pokrzywinski, Dennis Revicki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2003
No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North CarolinaJohnathan M Lancaster, Robert M Wenham, Susan Halabi, et al.
Critical Reviews in Oncology/Hematology|August 30, 2021
Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysisZiad Bakouny, Emre Yekedüz, David A Braun, et al.
International Journal of Cancer|May 8, 2000
ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancersH Peng, F Xu, R Pershad, et al.
Gynecologic Oncology Reports|July 26, 2016
Performance of sentinel lymph node biopsy in high-risk endometrial cancerJessie Ehrisman, Angeles Alvarez Secord, Andrew Berchuck, et al.
Gynecologic Oncology|February 15, 2003
Specific keynote: genome copy number abnormalities in ovarian cancerJoe W Gray, Seiji Suzuki, Wen-Lin Kuo, et al.
Leukemia Research|February 14, 2014
A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemiaDaniel J Deangelo, Donna Neuberg, Philip C Amrein, et al.
Gynecologic Oncology|June 3, 2006
Progestin and estrogen potency of combination oral contraceptives and endometrial cancer riskG L Maxwell, J M Schildkraut, B Calingaert, et al.
Gynecologic Oncology|July 1, 2008
Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrenceLaura J Havrilesky, Clark M Whitehead, Jennifer M Rubatt, et al.
Psychological Trauma : Theory, Research, Practice and Policy|September 22, 2015
Subthreshold posttraumatic stress disorder: A meta-analytic review of DSM-IV prevalence and a proposed DSM-5 approach to measurementMira Brancu, Monica Mann-Wrobel, Jean C Beckham, et al.
Pageof 69